Company Filing History:

5 out of 83

Lg Chemical Ltd.

patents

2 out of 10

Crystalgenomics, Inc.

patents

1 out of 14

Sbi Biotech Co., Ltd.

patents

4. 1 out of 623

Korea Research Institute of Chemical Technology

patents

where one patent can have more than one assignee

Years Active: 2001-2012

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8119812 - Thiazolidinone derivative (2012-02-21),

2. 8053435 - Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same (2011-11-08),

3. 6518429 - Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof (2003-02-11),

4. 6472526 - Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof (2002-10-29),

5. 6436960 - Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof (2002-08-20),

6. 6384061 - Hydantoin compounds and methods related thereto (2002-05-07),

7. 6268363 - Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof (2001-07-31),

Title: The Innovative Contributions of Seong Gu Ro

Introduction

Seong Gu Ro, an accomplished inventor based in Daejeon, South Korea, has made significant strides in the field of medicinal chemistry. With a total of seven patents to his name, his innovative work focuses primarily on compounds with promising therapeutic applications. His latest inventions highlight his commitment to advancing medical science and addressing critical health challenges.

Latest Patents

Among Seong Gu Ro's recent patents is the development of thiazolidinone derivatives. This invention aims to provide novel compounds that exhibit CDC7 inhibitory action, specifically designed to inhibit CDC7 protein kinase activity, which in turn suppresses cell proliferation. This discovery holds potential for use in cancer therapies.

Another notable patent involves the creation of naphthalenyloxypropenyl derivatives. These novel compounds are effective in inhibiting the enzyme activity of histone deacetylase, leading to the effective suppression of cancer cell proliferation. Such advancements demonstrate his innovative approach to tackling serious health issues through pharmaceutical research.

Career Highlights

Seong Gu Ro has garnered experience at prominent companies, including LG Chemical Ltd. and Crystalgenomics, Inc. His tenure at these organizations has allowed him to enhance his research capabilities and contribute to groundbreaking developments in pharmaceutical science.

Collaborations

Throughout his career, Seong Gu Ro has collaborated with notable colleagues, including Jong Sung Koh and Hyun Il Lee. These partnerships have been instrumental in fostering innovation and pushing the boundaries of scientific research.

Conclusion

Seong Gu Ro's contributions to innovation and invention in the pharmaceutical sector illustrate the impact of dedicated researchers in creating more effective treatments for diseases. His ongoing work and patent filings will undoubtedly pave the way for future advancements in medicinal chemistry.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.